SCHEMBL21476411

SCHEMBL21476411

c1ccc(-c2cccc(-c3nc(-c4ccc(-c5cc6ccccc6o5)cc4)nc(-c4ccc5oc6cc7ccccc7cc6c5c4)n3)c2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLA2G2A P14555 5/20 0.49
PLA2G4A P47712 5/20 0.49
PLA2G10 O15496 1/20 0.49
MAOB P27338 3/20 0.45
MAOA P21397 1/20 0.43
CA1 P00915 2/20 0.40
CA2 P00918 2/20 0.40
CA9 Q16790 2/20 0.40
ALOX5 P09917 1/20 0.40
PTPN1 P18031 2/20 0.39
RAB9A P51151 3/20 0.39
NPC1 O15118 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
ABCG2 Q9UNQ0 2/20 0.39
GABRP O00591 1/20 0.39
GABRD O14764 1/20 0.39
CA12 O43570 1/20 0.39
TNKS O95271 1/20 0.39
TP53 P04637 1/20 0.39
ABCB1 P08183 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21476525 0.96 PLA2G2A (0.48) PLA2G2APLA2G4APLA2G10MAOBMAOA
SCHEMBL21476393 0.95 PLA2G2A (0.48) PLA2G2APLA2G4APLA2G10MAOBMAOA
SCHEMBL21476775 0.94 PLA2G2A (0.44) PLA2G2APLA2G4APLA2G10MAOBMAOA
SCHEMBL21480655 0.92 PLA2G2A (0.46) PLA2G2APLA2G4APLA2G10MAOBMAOA
SCHEMBL21476770 0.91 PLA2G2A (0.42) PLA2G2APLA2G4APLA2G10MAOBMAOA
SCHEMBL19916945 0.90 PLA2G2A (0.42) PLA2G2APLA2G4APLA2G10RAB9ANPC1
SCHEMBL23334957 0.89 PGR (0.45) PLA2G2APLA2G4APLA2G10MAOBMAOA
SCHEMBL21476498 0.89 PLA2G2A (0.46) PLA2G2APLA2G4APLA2G10MAOBMAOA
SCHEMBL22138162 0.89 PLA2G2A (0.45) PLA2G2APLA2G4APLA2G10RAB9ANPC1
SCHEMBL21476369 0.89 PLA2G2A (0.53) PLA2G2APLA2G4APLA2G10MAOBMAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210130336-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2021-05-06 US disclosed
WO-2019198806-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE 出光興産株式会社 2019-10-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210130336-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE L1CAM, MLX, LEF1 PLA2G2A 3064/4885PLA2G4A 4054/4885PLA2G10 3711/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.